Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553097 · ClinicalTrials.gov registry record
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 51
- Enrollment target
NCT01553097 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 51 participants.
The verdict
NCT01553097 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects of these problematic side effects.
Interventions
- OTHER Neurocognitive impairment observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01553097
The ClinicalTrials.gov registry entry for NCT01553097 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurocognitive impairment observation is the first listed.
NCT01553097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01553097 about?
NCT01553097 is a clinical study titled "Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty". This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects ...
What is the current status of trial NCT01553097?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2012-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01553097?
The interventions under investigation include: Neurocognitive impairment observation (OTHER).
Who is sponsoring clinical trial NCT01553097?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.